Antimicrobial resistance survivors: calling the world to action

  24 May 2024

Antimicrobial resistance (AMR) remains a global threat, with slow progress in addressing it. The 2024 Lancet Series highlights the increasing burden of AMR, especially in low-income and middle-income countries, and the importance of vaccination programs, access to water, sanitation, hygiene, and infection control. It emphasizes the need to develop antimicrobials for priority pathogens and neglected infectious diseases, depending on the needs of affected populations. AMR affects vulnerable populations, including newborns, older people, and those with chronic illness. The series also highlights the individual stories and voices of AMR survivors and their caregivers, urging the world to recognize them as daughters, sisters, brothers, and sons and advocate for change.

Further reading: The Lancet
Author(s): Nour Shamas et al
Healthy Patients  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed